GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.464 32 days ( 56.95 % )
Last Price $2.43 8.00 %
High/ Low $2.28 - $2.49 0.654%
Chg 7 Days -2.80 % $2.50 $2.43
Chg 30 Days -20.59 % $3.06 $2.43
Chg 12 mos -19.27 % $3.01 $2.43
Trend - 3 mos -62.77 % Width: 49.40 %
Trend - 12 mos 62.33 % Width: 282.05 %
Pred. range - 3 mos $0.743 - $1.11 -69.41 % - -54.30 %
Pred. range - 12 mos $3.67 - $14.04 51.19 % - 477.61 %
Short MA avg 3 mos Buy Apr 19, 2024 - 2 days
Long MA avg 3 mos Sell Feb 06, 2024 - 53 days
Short/Long MA avg 3 mos Sell Feb 09, 2024 - 50 days
Short MA avg 12 mos Buy Mar 05, 2024 - 34 days
Long MA avg 12 mos Sell Mar 07, 2024 - 32 days
Short/Long MA avg 12 mos Sell Mar 11, 2024 - 30 days
Pivot Short Sell Apr 17, 2024 - 4 days
Bollinger Buy Sep 29, 2023 - 141 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT